levofloxacin


Also found in: Thesaurus, Medical, Encyclopedia, Wikipedia.
Related to levofloxacin: ciprofloxacin, Azithromycin

le·vo·flox·a·cin

 (lē′vō-flŏk′sə-sĭn)
n.
A synthetic broad-spectrum antibiotic, C18H20FN3O4, of the fluoroquinolone class.

American Heritage® Dictionary of the English Language, Fifth Edition. Copyright © 2016 by Houghton Mifflin Harcourt Publishing Company. Published by Houghton Mifflin Harcourt Publishing Company. All rights reserved.
Translations

levofloxacin

n levofloxacino, levofloxacina
English-Spanish/Spanish-English Medical Dictionary Copyright © 2006 by The McGraw-Hill Companies, Inc. All rights reserved.
References in periodicals archive ?
Significantly less adverse effects were observed in patients having levofloxacin as compared to standard triple therapy
Levofloxacin resistance in the Western Pacific region increased from 12% to 31% during the same two time periods (P less than .001).
Fluoroquinolones include levofloxacin (Levaquin), ciprofloxacin (Cipro), moxifloxacin (Avelox), gemifloxacin (Factive), and delafloxacin (Baxdela), and there are more than 60 generic versions.
The FDA conducted the postmarketing review on all five of the fluoroquinolones (ciprofloxacin, gemifloxacin, levofloxacin, moxifloxacin, and ofloxacin).
M2 EQUITYBITES-June 4, 2018-Lannett awarded US FDA approval for Levofloxacin Oral Solution, with expected imminent launch
M2 PHARMA-June 4, 2018-Lannett awarded US FDA approval for Levofloxacin Oral Solution, with expected imminent launch
A small retrospective review with in vitro samples indicated no difference in inpatient mortality with levofloxacin when comparing low, intermediate, and high MICs.
Among the non-[beta]-lactam agents, amikacin ([MIC.sub.50/90], 2/8 [micro]g/mL; 95.8/93.0% susceptible [CLSI/EUCAST]) was more active than colistin ([MIC.sub.50/90], [less than or equal to]0.5/>8 [micro]g/mL; 79.8% susceptible [EUCAST]), gentamicin ([MIC.sub.50/90],[less than or equal to]1/>8 [micro]g/mL; 72.0/71.3% susceptible [CLSI/EUCAST]), or levofloxacin ([MIC.sub.50/90], 0.25/>4[micro]g/mL; 65.7/63.8% susceptible [CLSI/EUCAST]).
To determine the synergistic effect, four standard antibiotic discs such as Amoxicillin, Ciprofloxacin, Azithromycin and levofloxacin were impregnated individually with 100[micro]l each of freshly prepared AgNPs and were placed onto the Mueller Hilton Agar medium inoculated with individual test organisms.
Based on the William Beaumont Army Medical Center (WBAMC) 2015 antimicrobial susceptibility report, * 88% of Pseudomonas isolates were susceptible to piperacillin-tazobactam, 77% of isolates were susceptible to levofloxacin, and 79% of isolates were susceptible to ciprofloxacin.
The antibiotics of intravenous piperacillin-tazobactam and levofloxacin were then started.